Home › Targets › B7-H3

B7-H3 (2 companies · 4 programs)

Companies with an active program directed at B7-H3.

Aktis Oncology, Inc. AKTS

[225Ac]Ac-AKY-2519 — Prostate Cancer Phase 1
[225Ac]Ac-AKY-2519 — Non-Small Cell Lung Cancer Phase 1
[225Ac]Ac-AKY-2519 Preclinical

Xencor Inc XNCR

XmAb808 — Solid Tumors Phase 1